Efficacy and Safety of Ruxolitinib Cream in Patients With Cutaneous Lichen Planus: A Randomized Clinical Trial.

Mangold AR, Lockshin B, Lai Z, Rong R, Nawaz H, Ehst BD

Open source

DOI
10.1001/jamadermatol.2026.3646
Published
2026 Sep 23
Container
JAMA dermatology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jamadermatol.2026.3646,
  title = {Efficacy and Safety of Ruxolitinib Cream in Patients With Cutaneous Lichen Planus: A Randomized Clinical Trial.},
  author = {Mangold AR and Lockshin B and Lai Z and Rong R and Nawaz H and Ehst BD},
  year = {2026},
  journal = {JAMA dermatology},
  doi = {10.1001/jamadermatol.2026.3646},
  url = {https://doi.org/10.1001/jamadermatol.2026.3646}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of Ruxolitinib Cream in Patients With Cutaneous Lichen Planus: A Randomized Clinical Trial.
AU  - Mangold AR
AU  - Lockshin B
AU  - Lai Z
AU  - Rong R
AU  - Nawaz H
AU  - Ehst BD
PY  - 2026
JO  - JAMA dermatology
DO  - 10.1001/jamadermatol.2026.3646
UR  - https://doi.org/10.1001/jamadermatol.2026.3646
ER  - 

APA

AR, M., B, L., Z, L., R, R., H, N., & BD, E. (2026). Efficacy and Safety of Ruxolitinib Cream in Patients With Cutaneous Lichen Planus: A Randomized Clinical Trial.. JAMA dermatology. https://doi.org/10.1001/jamadermatol.2026.3646

Source records